SRPT icon

Sarepta Therapeutics

409 hedge funds and large institutions have $10.2B invested in Sarepta Therapeutics in 2022 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 125 increasing their positions, 127 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

10% more funds holding

Funds holding: 373409 (+36)

2% less repeat investments, than reductions

Existing positions increased: 125 | Existing positions reduced: 127

6.84% less ownership

Funds ownership: 96.71%89.86% (-6.8%)

Holders
409
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
13
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$371M
Puts
$246M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.04B
2
$781M
3
$710M
4
$411M
5
$389M
6
$352M
7
$331M
8
$279M
9
$258M
10
$252M
11
$170M
12
$162M
13
$161M
14
$161M
15
$158M
16
$137M
17
$137M
18
$126M
19
$122M
20
$121M
21
$120M
22
$112M
23
$108M
24
$101M
25
$97.4M